Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Roche projects mid-single digit group sales growth in 2025, with core EPS growth in the high-single digit range. The company expects a CHF1.2 billion impact from the loss of exclusivity but aims to ...

However, the use of continuous glucose monitoring is on the rise and there is no study of the magnitude of the DCCT to affirm CGM-based metrics as standard for evaluating diabetes control,” said ...

Over the forecast period, CGM's market presence is expected to boost ... For instance, Abbott and Roche have been at the forefront of enhancing test strip accuracy and compatibility with mobile ...

Through this agreement, the company aims at making CGM devices available throughout North America ... operating in the global blood glucose meters market are F. Hoffmann-La Roche Ltd, Dexcom, Inc., B.

AI is now being included in CGM technology. For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien ...

AI is now being included in CGM technology. For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien ...

For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien Boisdron described it as “a solution more ...

Thomas Roche, 27, was last seen at 12:30 BST on 6 October when he left the flat he shared with his girlfriend in Chester Close, Bletchley, Buckinghamshire, for a cigarette. His sister Carly Roche ...